脂蛋白相关磷脂酶A2:一种独立血管风险预测因子和治疗新靶点

脂蛋白相关磷脂酶A2(lipoprotein-associated phospholipase A2,Lp-PLA2)可快速水解氧化低密度脂蛋白和脂蛋白(a)中的氧化磷脂分子,生成可溶性促炎和促凋亡介质-溶血卵磷脂和氧化游离脂肪酸,刺激单核巨噬细胞系统聚集和激活,诱导细胞凋亡和破坏死亡细胞的清除,在动脉粥样硬化脂质坏死核心的发展中起重要作用.Lp-PLA2不仅是冠状动脉疾病和缺血性卒中的独立风险标志物,而且在动脉粥样硬化斑块进展中起重要作用.选择性Lp-PLA2抑制剂可减少坏死核心的发展,可能对动脉粥样斑块起稳定作用,同时可能代表着一种动脉粥样硬化的治疗新靶点.

Lipoprotein-associated phospholipase A2:an independent predictor of vascular risk and a novel target for therapy

Lipoprotein-associated phospholipase A2(Lp-PLA2) can rapidly hydrolize and oxidize the oxidized phosphatidylcholine molecules produced in low density lipoprotein and atherogenic lipoprotein (a),generating the soluble proinflammatory and proapoptotic mediatorslyso-phosphatidylcholine and oxidized free fatty acids.It stimulates aggregation and activation of monocyte-macrophage system and induces apoptosis and damages the removal of dead cells.It plays an important role in the development of lipid necrotic core of atherosclerosis.Lp-PLA2 is not an independent risk marker of coronary artery disease and ischemic stroke,but also plays an important role in the development of atherosclerotic plaques.Selective Lp-PLA2 inhibitor reduces the development of necrotic cores.It may play a role in the stabilization of atherosclerotic plaques.At the same time,it may represent a novel target for the treatment of atherosclerosis.